CCL2 and early-onset autosomal dominant Alzheimer disease: Our results highlight a shared neuroinflammatory signature across Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD), characterized by the dysregulation of hub genes such as MMP9, S100A8, S100A9, CCL2, and LCN2.